Ad is loading...
JDVCX
Price
$15.71
Change
-$0.12 (-0.76%)
Updated
Nov 15 closing price
RLEFX
Price
$36.11
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

JDVCX vs RLEFX

Header iconJDVCX vs RLEFX Comparison
Open Charts JDVCX vs RLEFXBanner chart's image
JPMorgan Diversified C
Price$15.71
Change-$0.12 (-0.76%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R5E
Price$36.11
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
JDVCX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JDVCX vs. RLEFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDVCX is a StrongBuy and RLEFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 236B vs. JDVCX (475M). RLEFX pays higher dividends than JDVCX: RLEFX (2.42) vs JDVCX (0.61). JDVCX was incepted earlier than RLEFX: JDVCX (22 years) vs RLEFX (9 years). RLEFX is a more actively managed with annual turnover of: 171.00 vs. JDVCX (94.00). RLEFX has a lower initial minimum investment than JDVCX: RLEFX (250) vs JDVCX (1000). RLEFX annual gain was more profitable for investors over the last year : 21.09 vs. JDVCX (17.69). RLEFX return over 5 years is better than : 35.95 vs. JDVCX (-2.23).
JDVCXRLEFXJDVCX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years9 years-
Gain YTD10.26514.21172%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets475M236B0%
Annual Yield % from dividends0.612.4225%
Returns for 1 year17.6921.0984%
Returns for 3 years-15.5810.95-142%
Returns for 5 years-2.2335.95-6%
Returns for 10 years0.62N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYW111.330.52
+0.47%
SkyWest
TCBK47.59-0.02
-0.04%
TriCo Bancshares
WIT6.72-0.07
-1.03%
Wipro Limited
EDAP2.45-0.07
-2.78%
EDAP TMS SA
ELEV0.53-0.05
-8.41%
Elevation Oncology